Showing results (1-10 of 370) with videos related to
Sort By:
Pageof 37
Cancer|April 1, 2015
Rural-urban disparities in incidence and outcomes of neuroendocrine tumors: A population-based analysis of 6271 casesJulie Hallet, Calvin H L Law, Paul J Karanicolas, et al.Annals of Surgical Oncology|March 22, 2018
Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic MetastasesDavid L Chan, Matthew Dixon, Calvin H L Law, et al.Surgical Endoscopy|December 7, 2014
Lateral approach in laparoscopic distal pancreatectomy is safe and potentially beneficial compared to the traditional medial approachMatt Strickland, Julie Hallet, Daniel Abramowitz, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 5, 2022
Incidence of psychiatric illness in patients with neuroendocrine tumors: a comparative population-based analysisJulie Hallet, Elie Isenberg-Grzeda, Calvin H L Law, et al.Virchows Archiv : an International Journal of Pathology|April 17, 2013
Ki-67 is a reliable pathological grading marker for neuroendocrine tumorsAshlie Nadler, Moises Cukier, Corwyn Rowsell, et al.The Oncologist|July 5, 2019
Patterns of Symptoms Burden in Neuroendocrine Tumors: A Population-Based Analysis of Prospective Patient-Reported OutcomesJulie Hallet, Laura E Davis, Alyson L Mahar, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 21, 2018
Three point transfusion risk score in hepatectomy: an external validation using the American College of Surgeons - National Surgical Quality Improvement Program (ACS-NSQIP)Madeline Lemke, Alyson Mahar, Paul J Karanicolas, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 1, 2016
Patient Adherence and Experience with Extended Use of Prophylactic Low-Molecular-Weight Heparin Following Pancreas and Liver ResectionMadeline Lemke, Kaitlyn Beyfuss, Julie Hallet, et al.Cancer|October 15, 2014
Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomesJulie Hallet, Calvin How Lim Law, Moises Cukier, et al.Endocrine Oncology (Bristol, England)|August 7, 2024
Tolerability and outcomes of neuroendocrine tumors treated with PRRT and SBRTJose E Nunez, Sylvia Ng, Hanbo Chen, et al.Pageof 37